PharVision Advisers »

Marcus Corporation shares owned by PharVision Advisers

Quarter-by-quarter ownership of Marcus Corporation (MCS) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Marcus Corporation

Tip: Access up to 7 years of quarterly data

All positions including Marcus Corporation held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marcus Corporation by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-06-30 $180k 11k 16.86
2024-12-31 $298k 14k 21.50

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Marcus Corporation

BlackRock
Orbis Allan Gray
Dimensional Fund Advisors
Vanguard Group
Kitzinger Lautmann Capital Management
American Century Companies
GAMCO Asset Management
Geode Capital Management
State Street Corporation
Renaissance Technologies
Bridgeway Capital Management
Marshall Wace
Millennium Management
Acadian Asset Management
Barclays

View all funds holding Marcus Corporation